Sponsor pipeline

Quoin Pharmaceuticals clinical trial pipeline

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Phase 2/3

NCT ID	Title	Condition	Status	Updated
Phase 2/3
NCT07538583	Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome	Netherton Syndrome	Recruiting	2026-09-28
NCT05789056	Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton Syndrome	Netherton Syndrome	Recruiting	2026-08-31
NCT06953466	Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome	Netherton Syndrome	Recruiting	2026-08-31
NCT05521438	Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton Syndrome	Netherton Syndrome	Active, Not Recruiting	2026-03-16

Get alerts when Quoin Pharmaceuticals's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.